Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$5,894,897
+$420,908 QoQ
Shares Held
23,211
+3.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#1,494
of 4,676 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Premier Path Wealth Partners, LLC holds $28,672,526 across 10 Drug Manufacturers - General names. JNJ ranks #2 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,275 | $8,725,853 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
23,211 | $5,894,897 | |
| 3 | ABBV |
AbbVie Inc.
|
13,169 | $3,313,847 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,915 | $2,430,577 | |
| 5 | AMGN |
Amgen Inc
|
6,238 | $2,258,904 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
16,156 | $2,041,149 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
28,219 | $1,625,978 | |
| 8 | PFE |
Pfizer Inc
|
49,426 | $1,190,178 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,894,897 | 23,211 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $5,473,989 | 22,394 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $3,859,410 | 18,649 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $3,245,777 | 17,505 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,363,806 | 15,475 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,020,941 | 18,216 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $2,324,621 | 16,074 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,938,723 | 11,963 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,570,050 | 10,742 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,328,082 | 14,717 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $2,394,046 | 15,274 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||